• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HALYARD - IRVINE HOMEPUMP C-SERIES 125ML 5ML/HR; ELASTOMERIC LFR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HALYARD - IRVINE HOMEPUMP C-SERIES 125ML 5ML/HR; ELASTOMERIC LFR Back to Search Results
Model Number C125050
Device Problem Infusion or Flow Problem (2964)
Patient Problems Low Blood Pressure/ Hypotension (1914); Nausea (1970); Tachycardia (2095); Dizziness (2194); Decreased Sensitivity (2683)
Event Date 01/29/2019
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products and therapy dates: 300pu infusion of ropivacaine + 200 mcg of fentanyl.The sample is reported to be available, but has not yet been received by the manufacturer.A review of the device history record is in-progress.All information reasonably known as of 27-sep-2019 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.Avanos medical, inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical, inc.Complaint database and identified as complaint (b)(4).
 
Event Description
Fill volume: 125 ml.Flow rate: 5 ml/hr.Procedure: unknown.Cathplace: unknown.Day / time filled pump: (b)(6) 2019.Day / time start infusion: (b)(6) 2019.Day / time end infusion: (b)(6) 2019.Medication: 300pu infusion of ropivacaine and 200 mcg of fentanyl/ diluted in 80 ml of physiological solution, normal saline.It was reported after the surgery, the postoperative analgesia pump infused continuously.The device infused in 6-hours instead of 24-hours.The patient experienced dizziness, nausea, hypotension with a blood pressure 80/50 mmhg, tachycardia, sensory and motor block on legs.Medical intervention involved removing the equipment and administering 1000cc load of hartman solution plus 10 mg of ephedrine intravenous (iv).The pump was above the pump.The patient was eventually discharged.
 
Manufacturer Narrative
The product involved in the report has been returned and is being processed for evaluation.The device history record for the reported lot number, 0202861596, in this complaint was reviewed and the material was produced according to the manufacturing procedures and met the quality requirements.All information reasonably known as of (b)(6) 2019 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.The information provided by avanos medical, inc.Represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to avanos medical, inc.Avanos medical, inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical, inc.Complaint database and identified as complaint (b)(4).This information is submitted pursuant to 21cfr803, in compliance with the medical device reporting requirement and should not be considered to be an admission that an avanos medical, inc.Product is defective or caused serious injury.
 
Manufacturer Narrative
The sample device was evaluated.Flow rate testing was performed and the device met specifications.A root cause was not identified.All information reasonably known as of 26-feb-2020 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.The information provided by avanos medical, inc.Represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to avanos medical, inc.Avanos medical, inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical, inc.Complaint database and identified as complaint (b)(4).This information is submitted pursuant to 21cfr803, in compliance with the medical device reporting requirement and should not be considered to be an admission that an avanos medical, inc.Product is defective or caused serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HOMEPUMP C-SERIES 125ML 5ML/HR
Type of Device
ELASTOMERIC LFR
Manufacturer (Section D)
HALYARD - IRVINE
43 discovery
suite 100
irvine CA 92618
MDR Report Key9132164
MDR Text Key160907895
Report Number2026095-2019-00157
Device Sequence Number1
Product Code MEB
UDI-Device Identifier10680651135633
UDI-Public10680651135633
Combination Product (y/n)N
PMA/PMN Number
1
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,other
Type of Report Initial,Followup,Followup
Report Date 02/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/15/2020
Device Model NumberC125050
Device Catalogue Number101356302
Device Lot Number0202861596
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2019
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/06/2019
Initial Date FDA Received09/27/2019
Supplement Dates Manufacturer Received12/10/2019
02/03/2020
Supplement Dates FDA Received12/17/2019
02/27/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient Weight71
-
-